Loading company…
Shanghai Bioprofile provides precision medicine services in proteomics, metabolomics, genomics and transcriptomics.
Established in 2017 and based in Shanghai, China, Shanghai Bioprofile offers research and medical testing services in proteomics, metabolomics, genomics and transcriptomics for precision diagnostics, precision medication and drug target screening. It is recognized as a National High-tech Enterprise. In August 2023 it raised Series A funding led by new investor Zhonghuijin Group, with participation from returning investor Step Venture Capital.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in